HiberCell
HiberCell is a New York-based biotechnology company developing therapeutics to prevent relapse and metastasis.
2
Funding Rounds
$128.2m
Money raised
Overview
HiberCell is a New York-based biotechnology company developing therapeutics to prevent relapse and metastasis.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ar* No****** M.*** Ph*** |
|
- | - |
| Al** Ri**** Ph*** |
|
- | - |
| Ju*** Ag************ Ph*** |
|
- | - |
Funding series
Funding Series Analysis
The company HiberCell has raised a total of $67.4m in funding over 2 rounds.
Key Insights:
- HiberCell Series B round, May 2021: $67.4m
- HiberCell funding round, February 2019: $60.75m
HiberCell Series B round, May 2021
$67.4m
HiberCell funding round, February 2019
$60.75m
Industries
HiberCell is active in the following industries: